China Blood Products Market Report 2021 - COVID-19 Pandemic Brings Development Opportunities to Domestic Companies
Share this article Share this article ResearchAndMarkets.com's offering. With the adjustment in the catalog of medicines covered by national medical insurance system, the scope and reimbursement ratio of almost all blood products for clinical use grow tremendously, which has further opened up the blood product market. In 2020, the lot release volume of blood products in China sustained growth, hitting 101.31 million bottles, a year-on-year upsurge of 12.7%. Wherein, the lot release volume of human albumin rose 14.78% on an annualized basis, making up 60%; that of human immunoglobulin (pH4) f...
Source: prnewswire.com